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Abstract: Superparamagnetic iron oxide nanoparticles (SPIONs) are an exciting advancement 
in the field of nanotechnology. They expand the possibilities of noninvasive analysis and have 
many useful properties, making them potential candidates for numerous novel applications. 
Notably, they have been shown that they can be tracked by magnetic resonance imaging (MRI) 
and are capable of conjugation with various cell types, including stem cells. In-depth research 
has been undertaken to establish these benefits, so that a deeper level of understanding of stem 
cell migratory pathways and differentiation, tumor migration, and improved drug delivery can 
be achieved. Stem cells have the ability to treat and cure many debilitating diseases with limited 
side effects, but a main problem that arises is in the noninvasive tracking and analysis of these 
stem cells. Recently, researchers have acknowledged the use of SPIONs for this purpose and 
have set out to establish suitable protocols for coating and attachment, so as to bring MRI track-
ing of SPION-labeled stem cells into common practice. This review paper explains the manner 
in which SPIONs are produced, conjugated, and tracked using MRI, as well as a discussion on 
their limitations. A concise summary of recently researched magnetic particle coatings is pro-
vided, and the effects of SPIONs on stem cells are evaluated, while animal and human studies 
 investigating the role of SPIONs in stem cell tracking will be explored.
Keywords: stem cells, nanoparticle, magnetic
Introduction
Stem cells are omnipotent or pluripotent cells that are characterized by their self-renewal 
abilities through mitotic cell division, as well as by their potential for differentiation 
into a range of specialized cell types.1 Their unique properties have prompted a rapidly 
emerging field of regenerative medicine2 whereby damaged tissues are replaced with 
newly derived tissues constructed or seeded from appropriately differentiated stem 
cells.3 In order to secure the success of this form of stem cell therapy,4 it is essential 
that there is a safe way to track the movement of the implanted stem cells around the 
body, ensuring they reach their target tissue. Recent studies have reported the  imaging 
of stem cells using varied cell labeling techniques for the treatment of serious, debili-
tating diseases including ischemic stroke,5 skeletal dysplasia,6 spinal cord injury,7 and 
myocardial infarction.8
A popular form of high spatial resolution imaging used in stem cell studies is 
magnetic resonance imaging (MRI). It is non-ionizing, noninvasive, and has the 
 ability to produce three-dimensional images. Increased accuracy in image analysis 
can be achieved by using contrast agents. A popular contrast agent is superparamag-
netic iron oxide nanoparticles (SPIONs). SPIONs are small crystalline magnetite 
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structures  ranging in size from 5 nm to 150 nm9 which, when 
appropriately coated, become biocompatible and are readily 
endocytosed into the cell. They act as good contrast agents 
in MRI, enhancing the contrast between different tissues 
present by inducing a darker area (negative contrast). This 
is demonstrated in Figure 1, where 600 nm microgel iron 
oxide (M600) particles endocytosed into human fetal mes-
enchymal stem cells are imaged using transmission electron 
 microscopy. With no cellular toxicity and a high sensitivity 
for MRI, M600 particles are a good candidate for use as 
a contrast agent in cell tracking using MRI.  Additionally, 
 SPIONs can be used for drug delivery and diagnostic 
 purposes.  Theoretically, SPIONs appear to be perfect for 
clinical use; however, their stability, biocompatibility,10 and 
ability to locate and label the cell11 must be controlled and 
enhanced. In this review, we explain the means of produc-
tion of SPIONs and the different ways in which they are 
modified for specific stem cell tracking using MRI. We have 
also chosen to touch upon current research, both in animal 
and human studies that have utilized this technology, whilst 
discussing the potential limitations that exist.
What is a superparamagnetic  
iron oxide nanoparticle?
SPIONs are a form of iron oxide nanoparticle that exhibit 
superparamagnetism,12 a property similar to paramagnetism 
where a material shows magnetic properties only when under 
the influence of an external magnetic field. When such a field 
is present, as is produced by an MRI machine, the magnetic 
moments of the nanoparticle align in the direction of the 
applied field. No permanent magnetism is observed, and 
once the magnetic field is removed, the magnetic moments 
of the nanoparticle returns to being randomized by Brownian 
motion. Superparamagnetism is a property that is favorable 
for imaging, as it provides a higher tendency for the material 
to align with an applied magnetic field and a higher magneti-
zation of a material in response to the applied magnetic field.13 
Several forms of iron oxide exist but, magnetite (Fe
3
O
4
) and 
maghemite (γ-Fe
2
O
3
) SPIONs are particularly common in the 
literature.14 Numerous studies have been conducted concern-
ing these structures, leading to the development of many new 
possible applications and improvements on existing technol-
ogy using SPIONs, particularly in the field of biomedicine. 
These ideas exploit the rare superparamagnetic properties 
displayed by SPIONs for imaging with MRI.
Using SPIONs in magnetic  
resonance imaging (MRI)
MRI is a popular noninvasive, non-ionizing imaging tech-
nique that can be used to differentiate between pathological 
and healthy tissues. It is a powerful imaging method that is 
capable of providing insight into anatomical, physiological, 
and molecular processes, and it is often used for the diagnosis 
of diseases, the study of biological functions, and to identify 
cancer metastasis and inflammation.13 MRI is based upon 
the relaxation properties of hydrogen atoms in water. The 
human body is largely composed of water molecules, with 
each molecule containing two hydrogen nuclei (protons). 
When a patient is subjected to the powerful magnetic field 
generated by an MRI scanner, the magnetic moments of the 
protons in the water molecules align with the direction of the 
field. A radio frequency electromagnetic field is then briefly 
turned on, causing the magnetic moment of the protons to 
differ from that of the applied magnetic field. The electric 
field is then switched off and the protons “relax”, returning 
to their original, random alignment via Brownian motion; in 
doing so, the protons create a radio frequency signal detected 
by the scanner. The technique allows for the detection of 
pathological tissues, such as tumors, because the protons in 
different tissues return to their equilibrium states at different 
rates. Optimizing scanner parameters or using MRI contrast 
agents can enhance contrast between tissues of interest, 
allowing for clearer imaging of specific molecules, cells, or 
tissues. In fact, although MRI has become one of the main 
imaging techniques used in oncology, its resolution is mostly 
insufficient at a molecular and cellular scale, unless magnetic 
contrast agents are employed.15
Figure 1 Magnetic nanoparticles imaged in the cytoplasm of a stem cell.
Notes: A transmission electron microscopy image of a human fetal mesenchymal 
stem cell containing endocytosed microgel iron oxide particles (600 nm). Copyright 
© 2009 AlphaMed Press. Reproduced from Lee eS, Chan J, Shuter B, et al. Microgel 
iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through 
magnetic resonance imaging. Stem Cells. 2009;27(8):1921–1931.72
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SPIONs are effective contrast agents, owing to their 
superparamagnetic properties, high relaxivity,16 and high 
sensitivity in MRI, which leads to the use of very low con-
centrations, reducing their side effects.17 When SPIONs are 
present, they disturb the local magnetic field homogeneity 
and the large susceptibility differences between the iron oxide 
crystals and nearby protons, leading to a rapid dephasing of 
surrounding protons, resulting in a decrease in transverse 
(T2)18 and translational (T1) relaxation times. The shorter 
transverse relaxation time, in particular, results in a darker 
image being observed in the vicinity of the SPIONs; this is 
referred to as negative contrast. SPIONs have been shown 
to be more efficient and longer lasting than many other 
agents, and they importantly exhibit long blood retention 
times, biodegradability, and low toxicity.19 The magnetic 
properties of SPIONs can be manipulated by controlling the 
size of their core and coatings.20 The basic morphology of 
a SPION is a single-domain iron oxide core that is ,10 nm 
in size with a coating, which is most commonly dextran or 
a carboxy-dextran polymer.21 Nanoparticle aggregation can 
be prevented and biocompatibility improved by varying the 
nature of the coating applied to the core. The coating is thick 
compared to the core and is, therefore, the main contributor to 
the hydrodynamic size. The size of the particle will inevitably 
determine the overall chemical and physiological properties 
of the nanoparticle.22 A diagram of the basic structure of a 
magnetic nanoparticle (MNP) can be seen in Figure 2. The 
figure details a magnetic core which, in the context of this 
article, is comprised of iron oxide, a protective coating, and 
active molecules, bound to the coating by organic linkers. 
Bound active molecules (a form of surface modification) are 
used to tailor the nanoparticle for specific applications.
Stem cell tracking
The localization of stem cells has attracted increasing 
amounts of interest in the field of biomedical science 
in recent years due to the vast potential to revolutionize 
 treatment for an extensive range of pathologies. To ensure 
that these treatments are a success, the fate of the stem cells, 
their functional capabilities, and the role that they play 
biologically must be determined. Labeling stem or progeni-
tor cells with SPIONs allow their migration pattern to be 
non-invasively monitored in vivo with MRI. This has the 
possibility to help monitor stem cell therapy in the treatment 
of diseases such as myocardial infarctions,23 neurological 
diseases, and cancer.24 Success has recently been reported 
in a rat model of Huntington’s disease.24 Figure 3 shows an 
MRI of SPION-labeled mesenchymal stem cells (MSCs) in 
vivo, which could be imaged 60 days post-implantation. The 
labeled MSCs showed no sign of reduced cell viability, pro-
liferation, or differentiation and, importantly, the number of 
degenerating neurons was reduced. This was ascertained by 
using techniques developed in previous research by Jasmin 
et al,25 which included use of a live/dead viability/toxicity 
kit. The results showed that while, on its own, MRI  imaging 
can only really highlight the position of stem cells in the 
body, combing techniques such as computed tomography, 
positron emission tomography,26 single-photon emission 
computed tomography, and optical imaging provide a wide 
array of data, which could be gathered to present a clearer 
picture of biodistribution differentiation, cell viability, 
and function.27
Magnetic nanoparticle
Spacer arm
Biocompatible coating
Active molecule
Figure 2 A basic schematic diagram of a magnetic nanoparticle’s structure.
Note: A magnetic nanoparticle consists of magnetic core, a protective coating, and 
a linker connecting active molecules.
Figure 3 Magnetic resonance imaging (MRI) of rats with neurodegenerative disease 
injected by mesenchymal stem cells labeled with magnetic nanoparticles.
Notes: In both MRI images (sagittal A and horizontal B) a dark area, identified by a 
white arrow, is present. This indicates a large concentration of SPION-labeled 
mesenchymal stem cells. Reprinted from Stem Cell Res, 9(2), Moraes L, vasconcelos-
dos-Santos A, Santana FC, et al, Neuroprotective effects and magnetic resonance 
imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington’s 
disease, 143–155, Copyright (2012), with permission from elsevier.21
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The future for the use of SPIONs in stem cell tracking is 
hopeful. In theory, information gained from stem cell tracking 
could lead to optimized dosages, preferred sites of engraft-
ment, and specialized timing of stem cell injections,28 allow-
ing for the tailoring of treatments to individual patients.
Although the future is promising, if the tracking of 
SPION-labeled stem cells is to gain widespread use in clinical 
cellular therapies, it is essential to explore:
1. different coatings used to form biocompatible and long-
lived SPIONs;
2. the synthesis of the chosen coated SPIONs;
3. uptake of SPIONs into specific stem cells; and
4. the limitations involved in SPION stem cell tracking.
In this review, we will cover these topics, providing a 
clear understanding of the processes involved in stem cell 
tracking using SPIONs.
Synthesis and labeling of magnetic 
iron oxide particles
Many different chemical methods for synthesizing MNPs 
are available, including thermal decomposition, hyper-
thermal, coprecipitation, solvo–thermal route, and sol–gel 
methods. Most commonly used is the precipitation-based 
approach, which is achieved either by coprecipitation or 
reverse micelle synthesis. This is shown in Table 1, which 
outlines the various research groups who showed that 
decomposition methods can produce MNPs with more 
favorable magnetic properties when compared to those 
formed by coprecipitation. The choice of the core of the 
MNP is an important factor when producing MNPs. The 
majority of the studies detailed in Table 1 use iron oxide, 
due to its biocompatibility and low toxicity. Iron oxide 
nanoparticles without a surface coating are not viable in 
aqueous medium and, therefore, will readily aggregate and 
precipitate.
In vivo experimental results show that particles will form 
aggregates in the blood, resulting in unwanted sequestra-
tion by macrophages.29 In order to counteract this effect, 
the surface of SPIONs has been functionalized to enhance 
biocompatibility. Table 2 details many of the coatings used 
in the literature and the effect that they have on the nanopar-
ticle. The process of nanoparticle coating can be achieved 
by different mechanisms. Two common methods of doing 
so include:
1. in situ coatings whereby the SPION is coated during the 
process of synthesis and post-synthesis;28 and
2. liposome encapsulation to create magnetoliposomes, 
adding a more hydrophobic nature to the particle.30
After coating, the SPION can be used to label the cells. 
This is achieved by one of two methods:
1. Attaching the nanoparticle to the surface of the stem 
cell.
2. Internalizing the biocompatible SPION by endocytosis 
or phagocytosis.
It is important to note that the first method, surface 
 labeling, is limited to in vitro settings, as the method is 
generally unsuitable for use in vivo models due to clearance 
of the labeled cells from rapid reticuloendothelial recogni-
tion.31 In the internalization method, the SPION can enter the 
cell via either receptor-mediated interactions or nonspecific 
internalization pathways.
In both cases, the nanomaterials become entrapped 
within the endosomes and are released into the cytoplasm. 
Human stem cells, such as mesenchymal stem cells, can 
internalize nanoparticles, even in the absence of transfection 
agents.32 In most cases, however, the internalization of the 
SPION requires the use of an inactive substance that can be 
used as a carrier for an active ingredient, also known as an 
excipient.15
A comparison of different  
coats for SPIONs
The success of labeling stem cells with SPIONs is usually 
advanced by encasing the nanoparticle in a biocompatible 
coating. The correct choice of coating will ensure stability, 
solubility, and prevent aggregation of the SPIONs. Often a 
transfection agent is used, which promotes a quicker and 
significantly more efficient uptake of the label into the cell. 
Some common examples are poly-L-lysine (PLL), sulfate, 
and protamine.29 It is important to not only choose the cor-
rect coating, but also to use the correct concentration of the 
transfection agent. This is highlighted in Figure 4, in which 
protamine is used as a transfection agent for the MNP,  Feridex 
(Ad-Vance Magnetics Inc, Rochester, IN, USA). At a low 
concentration (1 µg/mL) of protamine, a lower percentage of 
mesenchymal stem cells are labeled than at the recommended 
concentration of protamine (5 µg/mL), in which 95% of the 
cells are labeled. After a transfection agent has been applied, 
the nanoparticles are incubated overnight in the appropri-
ate stem cell medium, which facilitates a passive uptake of 
the nanoparticles. Notable and interesting exceptions are 
epithelial cell adhesion molecule beads, which utilize anti-
gens that are specifically present on the human hepatic stem 
cells. Exterior attachment of the label is achieved by specific 
antibodies manufactured on the surface of the nanoparticle, 
which are complimentary to the antigen on the human hepatic 
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stem cells. The usual process of passive uptake is often close 
to being 100% successful, meaning that in general, the labels 
are evaluated by the effect that they have on stem cells, their 
relaxivity, and the time in which they remain detectable by 
MRI.33
A wide array of different nanoparticles and coatings 
has been reported in the literature with impressive results.33 
For the most part, ferumoxide, ferucarbotran, and Feridex 
SPIONs coated with different materials (such as dextran 
and carboxydextran) are used, as they are approved for 
human use. A specific example of human use is shown in 
Figure 5, in which neural stem cells are labeled by the nano-
particle,  Feridex, which is coupled to the transfection reagent, 
Effectene® (Qiagen, Venlo, the Netherlands). A lesion in the 
left temporal lobe is highlighted with an asterisk and no signal 
is seen (Figure 5A) on the MRI image before the implantation 
of the labeled stem cell. One day later, implantation signals 
were observed (Figure 5B), indicating the presence of the 
labeled neural stem cells at the legion site. A clear, concise 
summary of the effect of some commonly used magnetic 
nanoparticles is given in Table 2. The method of labeling, the 
percentage of the cells labeled, how long the label remains 
in the cell, and the effect of the presence of the label in the 
cell is detailed. Other nanoparticles have been tested and 
evaluated as MRI contrast agents (for example, gold, MnO, 
and CoPt); however the sheer volume of literature available 
regarding coated SPIONs confirms their superiority as a 
contrast agent in the field of stem cell tracking.
In vivo animal studies
The in vivo tracking of stem cells using SPIONs has already 
been extensively studied in various animal models. Jing 
et al,34 using the Feridex–protamine sulfate complex as the 
SPION, as well as transfection agents, tracked mesenchymal 
stem cells in the articular cartilage within the knee joints of 
rabbits. The study showed that there were no changes in the 
viability, proliferation, or differentiation of the labeled stem 
cells in comparison to the non-labeled cells when examined 
at a concentration of 25 µM. Once the labeled stem cells were 
intra-articularly injected, upon gradient echo sequence–T2 
weighted signals, areas of hypointense signals could be seen 
on imaging and were apparent for at least 12 weeks after the 
initial injection. Comparable results were also seen in a study 
by Hu et al,35 in which human umbilical cord mesenchymal 
stem cells were transplanted surgically into the spinal cord 
of an adult rat. Once again, the researchers used Feridex 
coating for the SPION, at 22.4 µg coating for the SPION 
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a markedly hypointense area in the region transplanted with 
SPION-labeled human umbilical cord mesenchymal stem 
cells and, more importantly, that the transplanted labeled cells 
were found to be more hypointense than non-labeled cells. 
It was also determined that the stem cells were accurately 
detectable 2 weeks after the initial transplant. It is, further-
more, important to note that both Jing et al34 and Hu et al35 
identified that the extent of the signal intensity changes 
expressed by SPION-labeled stem cells was dependent on 
the number of labeled stem cells at any one time, and that 
this number could decrease significantly over time. The role 
of stem cells in myocardial repair following myocardial 
infarction or insult has yet been established.
A study by Amsalem et al47 used SPIONs, coated with 
ferumoxide and complexed to PLL, to track MSC after being 
injected into the rats, 7 days after inducing a myocardial 
infarction. The authors found that after 1 week, 2 weeks, and 
4 weeks, the MRI demonstrated well-defined hypointense 
areas in the rats that were injected with SPION-labeled 
MSCs, while control specimens injected with saline or 
unlabeled MSCs showed no areas of hypointensities. There 
was retention of the magnetic signal throughout the 4-week 
period, and this was comparable among both groups of rats 
(those that had suffered a myocardial infarction, and those 
that had not). Another group of researchers, Chapon et al,36 
used dextran-coated SPIONs to track bone marrow-derived 
mesenchymal stem cells to determine their effect in host 
cardiac tissue after a myocardial infarction. It was shown 
that the SPION-labeled stem cells could be tracked for up 
to 6 weeks after the initial stem cell injection using MRI. 
In addition, the study also demonstrated that there was a 
larger uptake of stem cells in infarcted tissue, as shown by 
the positron emission tomography study, in which radiola-
beled glucose (2-deoxy-2-[F-18] fluoro-D-glucose [FDG]) 
was used to determine glucose uptake of the cells at the 
infarcted areas. While the study showed that despite the 
increased uptake of bone marrow-derived mesenchymal 
stem cells in the infarcted areas there was no improved left 
ventricular function in the rats, it did highlight the ability to 
track the stem cells. Although promising, some limitations 
and questions arose from the research concerning the best 
medium and cell surface coating to use in order to optimize 
stem cell tracking, and as such, further in vivo work would 
need to be conducted.
Further research conducted by Delcroix et al37 in 2009 
investigated how stem cell tracking in neural migratory 
pathways could be potentially used for clinical therapy. 
The researchers used SPIONs, which were coated with 
1-hydroxyethylidene-1.1-bisphosphonic acid to label rat 
mesenchymal stem cells.37 It had already been established 
that in an appropriate environment, which contains particular 
matrix molecules and growth factors, mesenchymal stem 
cells were able to transdifferentiate into neural cells in vitro, 
though very little work had been done in vivo. Delcroix 
et al37 incubated the rat mesenchymal stem cells (rMSCs) 
for 48 hours with 50 ug/mL of 1-hydroxyethylidene-1. 
1-bisphosphonic acid (HEDP)-coated SPIONs. They estab-
lished that there was no effect or change in the morphology 
or viability of the rMSCs. At this point, it was discovered 
that by using an MRI, there was a long distance of migration 
in rMSC from the subventricular zone to the olfactory bulb 
via the rostral migratory system. The value of the research 
conducted by Delcroix et al37 demonstrated for the first 
time that neural migratory pathways can be established and 
mapped out using SPIONs. The importance of identifying 
stem cell migratory mechanisms in response to injury could 
eventually lead to the use of MSCs in brain cell therapy, and 
it further establishes that additional research is required as to 
why, despite in vitro models suggesting that transdifferentia-
tion of MSCs into neural cells, this is not the case in vivo. 
There is considerable promise and established research that 
demonstrates that SPIONs have an exciting role in stem cell 
tracking by non-invasive mechanisms which could, in time, 
lead to deeper appreciation of tissue regeneration pathways 
and future clinical applications.
Human studies
There is a great potential role for the in vivo, non-invasive 
tracking of transplanted human stem cells, as there is scope 
for obtaining real-time insights into underlying physiological 
and cellular responses of stem cells in both normal function-
ing and pathological injury. As was discussed with the animal 
studies, understanding migratory pathways and the manner 
in which different stem cells differentiate to site-specific 
cells can be crucial in the development of clinical therapies. 
In order for long-term clinical therapies to be introduced, 
there is a necessary evolution in research that has to occur, 
as animal models need to progress to human models before 
clinical trials can take place.
It is important to take into account the variable factors 
that make clinical trials on humans more challenging than 
simply repeating an experiment, as deduced from research 
on animal models. For example, the organism’s weight, blood 
volume, cardiac output, and intra- as well as inter-cellular 
microenvironments are markedly different from one animal 
to another; as such, human studies would require careful 
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planning and assurance of safe testing before moving ahead.38 
Although only a few studies have been done, research has 
indeed showed that there is effective non-invasive tracking 
of labeled human embryonic stem cells using MRI imag-
ing. The first study that attempted clinical MRI tracking of 
therapeutic cells in humans was first reported in 2005.39 The 
researchers co-cultured immature dendritic cells with 200 
µg/ml SPION.39 They confirmed that the dendritic cells had 
taken up a significant amount of SPION before the end of the 
culture period. Following intranodal injection into eight grade 
3 melanoma patients, 3T MRI along with scintigraphy was 
used to image the injected cells. The results showed that MRI 
imaging was at least as sensitive an imaging modality as scin-
tigraphy, and it also managed to track the cells with a higher 
degree of accuracy due to its superior spatial resolution. de 
Vries et al39 noted in their work that 50% of the ultrasound-
guided injections of stem cells were misadministered into 
nodes adjacent to the target lymph node and, importantly, this 
was only revealed on subsequent MRI imaging.  Identifying 
this error, however, showed that SPION-labeled cells could 
be tracked using MRI, and they could also be used to ensure 
that cells are injected or delivered to the correct target site. 
In 2008, Zhu et al40 conducted a case study on two patients: 
one of which was a 34-year-old man who had brain trauma 
Table 2 An analysis of the MNPs for their use in stem cell tracking using MRI
Year Type of MNP How stem cells attached  
to SPIONs
Method of production  
of label
Clinical application In vivo/in vitro % of stem cells  
labeled
Effect on stem cells How long the label  
remained detectable
Other
201148 Gold nanoparticle coated  
with PLL or citrate solution
Passive uptake of the  
nanoparticles by the cells
Gold nanoparticles coated  
with PLL added to cell culture  
and incubated for 24 hours
MSC labeling, imaging, and  
tracking
In vitro (LIve/ 
DeAD stain)
NR Not cytotoxic to the cells and did 
not substantially affect viability
NR Cell uptake of the  
nanoparticle decreased
201132 USPIO-PS Passive uptake of the  
nanoparticles by the cells
USPIOs are composed of  
maghemite cores modified on  
their surface by amino silane  
coupling agents
Labeling of hADSCs to assess  
their fate in vivo on a three- 
dimensional, porous scaffold
Mouse 91% Not toxic for the cells apart from 
a slight loss of metabolic activity at  
days 11 and 14 compared to the  
unlabelled cells
28 days after  
implantation
USPIO allowed the  
visualization of 5 × 104  
labeled hADSCs by MRI
201165 Fe-Pro Passive uptake of the  
nanoparticles by the cells
Ferumoxide–protamine sulfate  
complex was made with  
ferumoxides mixed with  
protamine sulfate solution
Labeling hB MSCs with Fe-Pro 
to be tracked by MRI
ex vivo 95% Did not harm cells or influence their 
behavior, including viability, long- 
term metabolic cell activity
NR Transfection with protamine 
sulfate leads to a higher  
uptake
201166 Mesoporous silica-coated  
hollow manganese oxide  
(HMnO@mSiO2)  
nanoparticles
electroporation MnO nanoparticles were  
prepared, stabilized, and coated  
with a silica coating
MRI tracking of MSC using  
HMnO@mSiO2 as a positive  
marker
Mouse 26% with  
electroporation
Minimal impact on cell viability 14 days Significantly higher relativity 
versus existing manganese  
oxide nanoparticles
201167 CoPt hollow nanoparticles Passive uptake of the  
nanoparticles by the cells
CoPt nanoparticles were  
synthesized and coated with a  
mixture of PeG-SH and CCALNN  
peptide
MRI tracking of grafted NSCs  
labeled with CoPt
In vitro NR No impact on cell viability,  
morphology, or proliferation at low 
concentrations of CoPt nanoparticles
Detectable at low cell  
numbers with MRI  
after 2 weeks
Optimized when NSCs  
exposed to 8 mg mL-1 and  
16 mg mL-1, and CoPt for  
48 hours
200968 SPIONs with a  
carboxydextran coating
Passive uptake of the  
nanoparticles by the cells  
by endoplasmic absorbtion
MSCs culture medium was  
incubated for 24 h with  
Ferucarbotran
Labeling and therefore  
tracking MSCs in the kidney  
of a dog
Dog PLL coating 
Has a higher labeling  
efficiency than ferumoxide
Impaired viability and/or apoptosis 
at higher conc. 
No affect on cell viability and  
proliferation
NR Can label efficiently without 
transfer agent
200969 SPIO@SiO2-NH2 Passive uptake of the 
nanoparticles by the cells
Polyhedral crystalline SPIO  
nanoparticles were prepared  
by a coprecipitation method
Tracking MSCs using SPIO@ 
SiO2-NH2 with MRI
Rabbit Increased MSC- 
labeling effects
Displayed normal nuclear  
morphology, apoptosis, and necrosis  
changes were not observed
12 weeks NR
201070 Chitosan–SPIONs  
coated in PLL
Passive uptake of the  
nanoparticle by the cells  
using endocytosis
Chitosan–SPIO synthesized by a  
sono-chemical method followed  
by a chitosan coating process
Label and track hBM–MSC  
using MRI
Rabbit Almost 100% Did not show any cytotoxicity up to  
a 200 mg Fe/mL concentration
2 weeks NR
200760 MGIO Passive uptake of the  
nanoparticles by the cells  
via endocytosis
Nonmagnetic PMG synthesized  
then magnetized by the  
coprecipitation of iron salt to  
form primary iron oxide cores  
within PMG
Labeling hfMSCs for MRI  
tracking with MGIO
Rat 97% There was no affect on cellular  
proliferation
M600 particles could  
be detected even after 
four cellular divisions
M600 achieved a five- to  
sevenfold higher sensitivity  
for MRI detection than  
ferucarbotran
200971 SPION coated  
with starch
Passive uptake by the cells SPIONs coated in starch were  
synthesized. 
Incubation with nanoparticles in  
the cell culture medium
Labeling and tracking MSCs 
using SPIONs
NR Uptake was  
proven but not  
quantified
Cells able to differentiate into  
stromal tissue, including bone and  
fat
28 days; could visualize  
1,000 MSCs
No MRI signal with the use 
of free iron- or dead iron- 
labeled MSCs
Abbreviations: MNPs, magnetic nanoparticles; MRI, magnetic resonance imaging; SPIONs, superparamagnetic nanoparticles; PLL, poly-L-lysine; MSC, mesenchymal cells; 
NR, not reported; USPIO-PS, ultrasmall superparamagnetic iron oxide; hADSCs, human adipose-derived stem cells; Fe-PRO, ferumoxide-protamine sulfate complex; 
hB, human bone; CoPt, cobalt platinum; PeG-SH, polyethylene glycol; CCALNN, cysteine-cystein-alanine-leucine-asparagine; NSC, neural stem cells; SPIO, superparamagnetic 
iron oxide; MGIO, microgel iron oxide; PMG, precursor microgel; hfMSC, human fetal mesenchymal cells.
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in his left temporal lobe in 2004; and a control 42-year-old 
male who had brain trauma in his right temporal lobe. Neural 
tissue from both patients was taken during emergency opera-
tions, and the test patient had his neural tissue incubated with 
Feridex SPIONs and a lipofection transfection agent.40 The 
SPION-labeled neural stem cells were then injected around 
the region of the brain damage and 3T MRI was performed 
at 24 hours, then every 7 days after transplantation for 10 
weeks. Before implantation, upon T2 weighted MRI imaging, 
no pronounced hypointense signals were found, although 
the injection sites themselves produced a circular area of 
dark tissue on imaging. This hypointense signal at the injec-
tion sites faded after a week or so. In terms of the injected 
cells themselves, a hypointense signal was seen around the 
border of the damaged tissue in the temporal lobe, and it 
intensified at around weeks 2 and 3, before eventually fading 
after 7 weeks, most likely due to dilution of the SPIONs in 
response to cell proliferation around the site of the lesion. 
In the control patient, however, there was no change in the 
signal on MRI during the observation over the trial period, 
although there was a slight hypointense signal at the injection 
sites. The researchers concluded that stem cell migration 
after implantation could indeed be detected via non-invasive 
methods using SPIONs and MRI.
Table 2 An analysis of the MNPs for their use in stem cell tracking using MRI
Year Type of MNP How stem cells attached  
to SPIONs
Method of production  
of label
Clinical application In vivo/in vitro % of stem cells  
labeled
Effect on stem cells How long the label  
remained detectable
Other
201148 Gold nanoparticle coated  
with PLL or citrate solution
Passive uptake of the  
nanoparticles by the cells
Gold nanoparticles coated  
with PLL added to cell culture  
and incubated for 24 hours
MSC labeling, imaging, and  
tracking
In vitro (LIve/ 
DeAD stain)
NR Not cytotoxic to the cells and did 
not substantially affect viability
NR Cell uptake of the  
nanoparticle decreased
201132 USPIO-PS Passive uptake of the  
nanoparticles by the cells
USPIOs are composed of  
maghemite cores modified on  
their surface by amino silane  
coupling agents
Labeling of hADSCs to assess  
their fate in vivo on a three- 
dimensional, porous scaffold
Mouse 91% Not toxic for the cells apart from 
a slight loss of metabolic activity at  
days 11 and 14 compared to the  
unlabelled cells
28 days after  
implantation
USPIO allowed the  
visualization of 5 × 104  
labeled hADSCs by MRI
201165 Fe-Pro Passive uptake of the  
nanoparticles by the cells
Ferumoxide–protamine sulfate  
complex was made with  
ferumoxides mixed with  
protamine sulfate solution
Labeling hB MSCs with Fe-Pro 
to be tracked by MRI
ex vivo 95% Did not harm cells or influence their 
behavior, including viability, long- 
term metabolic cell activity
NR Transfection with protamine 
sulfate leads to a higher  
uptake
201166 Mesoporous silica-coated  
hollow manganese oxide  
(HMnO@mSiO2)  
nanoparticles
electroporation MnO nanoparticles were  
prepared, stabilized, and coated  
with a silica coating
MRI tracking of MSC using  
HMnO@mSiO2 as a positive  
marker
Mouse 26% with  
electroporation
Minimal impact on cell viability 14 days Significantly higher relativity 
versus existing manganese  
oxide nanoparticles
201167 CoPt hollow nanoparticles Passive uptake of the  
nanoparticles by the cells
CoPt nanoparticles were  
synthesized and coated with a  
mixture of PeG-SH and CCALNN  
peptide
MRI tracking of grafted NSCs  
labeled with CoPt
In vitro NR No impact on cell viability,  
morphology, or proliferation at low 
concentrations of CoPt nanoparticles
Detectable at low cell  
numbers with MRI  
after 2 weeks
Optimized when NSCs  
exposed to 8 mg mL-1 and  
16 mg mL-1, and CoPt for  
48 hours
200968 SPIONs with a  
carboxydextran coating
Passive uptake of the  
nanoparticles by the cells  
by endoplasmic absorbtion
MSCs culture medium was  
incubated for 24 h with  
Ferucarbotran
Labeling and therefore  
tracking MSCs in the kidney  
of a dog
Dog PLL coating 
Has a higher labeling  
efficiency than ferumoxide
Impaired viability and/or apoptosis 
at higher conc. 
No affect on cell viability and  
proliferation
NR Can label efficiently without 
transfer agent
200969 SPIO@SiO2-NH2 Passive uptake of the 
nanoparticles by the cells
Polyhedral crystalline SPIO  
nanoparticles were prepared  
by a coprecipitation method
Tracking MSCs using SPIO@ 
SiO2-NH2 with MRI
Rabbit Increased MSC- 
labeling effects
Displayed normal nuclear  
morphology, apoptosis, and necrosis  
changes were not observed
12 weeks NR
201070 Chitosan–SPIONs  
coated in PLL
Passive uptake of the  
nanoparticle by the cells  
using endocytosis
Chitosan–SPIO synthesized by a  
sono-chemical method followed  
by a chitosan coating process
Label and track hBM–MSC  
using MRI
Rabbit Almost 100% Did not show any cytotoxicity up to  
a 200 mg Fe/mL concentration
2 weeks NR
200760 MGIO Passive uptake of the  
nanoparticles by the cells  
via endocytosis
Nonmagnetic PMG synthesized  
then magnetized by the  
coprecipitation of iron salt to  
form primary iron oxide cores  
within PMG
Labeling hfMSCs for MRI  
tracking with MGIO
Rat 97% There was no affect on cellular  
proliferation
M600 particles could  
be detected even after 
four cellular divisions
M600 achieved a five- to  
sevenfold higher sensitivity  
for MRI detection than  
ferucarbotran
200971 SPION coated  
with starch
Passive uptake by the cells SPIONs coated in starch were  
synthesized. 
Incubation with nanoparticles in  
the cell culture medium
Labeling and tracking MSCs 
using SPIONs
NR Uptake was  
proven but not  
quantified
Cells able to differentiate into  
stromal tissue, including bone and  
fat
28 days; could visualize  
1,000 MSCs
No MRI signal with the use 
of free iron- or dead iron- 
labeled MSCs
Abbreviations: MNPs, magnetic nanoparticles; MRI, magnetic resonance imaging; SPIONs, superparamagnetic nanoparticles; PLL, poly-L-lysine; MSC, mesenchymal cells; 
NR, not reported; USPIO-PS, ultrasmall superparamagnetic iron oxide; hADSCs, human adipose-derived stem cells; Fe-PRO, ferumoxide-protamine sulfate complex; 
hB, human bone; CoPt, cobalt platinum; PeG-SH, polyethylene glycol; CCALNN, cysteine-cystein-alanine-leucine-asparagine; NSC, neural stem cells; SPIO, superparamagnetic 
iron oxide; MGIO, microgel iron oxide; PMG, precursor microgel; hfMSC, human fetal mesenchymal cells.
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As of yet, not many human subject studies have been done 
using SPIONs, but even from the brief research that has been 
conducted, there seems to be legitimate and effective results 
showing the promising use of SPIONs in stem cell tracking 
using non-invasive mechanisms, such as MRI. Of course, 
dependent on the progress of work in animal models, human 
studies can progress. Much will still need to be done to obvi-
ate the use of transfection agents, which may be attributed 
to cell death, and to assess the most appropriate and suitable 
method of labeling stem cells. 
The limitations of MRI  
and the use of SPIONs
The limitations of MRI are well illustrated in their use of 
stem cell tracking. First, due to cell division, the SPION-
labeled cells become diluted in a localized site and, conse-
quently, the generated image is weakened or distorted. This 
has been seen in neural stem cells where the concentration 
of SPIONs was shown to decrease by 50% every 3 days 
in vitro. Second, due to the in vivo migration of SPION-
labeled stem cells, the density of the cells is considerably 
reduced over time, again leading to a weakening of the MRI 
signal.24 Third, SPION cell labeling itself cannot determine 
if or what the SPION-labeled stem cell differentiates into, 
although through the use of combined imaging techniques 
such as immunohistochemistry and confocal microscopy, the 
function of the stem cell can be ascertained.41 Fourth, most 
studies utilizing MRI are conducted with a 1.5T MRI unit, 
which has a limited spatial resolution and does not allow 
for deep imaging. An improvement in spatial resolution can 
only be achieved through the use of stronger magnetic fields, 
and it is still unknown what effect this would have upon the 
cells.42 Fifth, SPIONs are not detected directly; rather, they 
are detected through indirect microscopic disturbances in 
the magnetic field. As a result of this, it proves harder to 
correlate the magnetic resonance signal with the number 
of cells present.43 Another commonly encountered problem 
is that if cells die, they will still be imaged by MRI, as the 
SPIONs will remain inside or attached to the cell. This 
invariably leads to an inaccurate analysis of the MRI image, 
especially since it is likely that these dead cells are engulfed 
by macrophages, which would lead to contrast agents being 
present in the lymph nodes.
SPIONs come with an inherent risk of toxicity, as is the 
case with any foreign particle or chemical that is injected or 
administered within an organism. SPIONs are composed of 
biodegradable iron, which could potentially be recycled by 
cells within the body that use biochemical pathways for iron 
metabolism. This would lead to a situation of iron-mediated 
Figure 4 Application of transfection agents to encourage a swift uptake of magnetic nanoparticles by stem cells.
Notes: Conjugating protamine to magnetic nanoparticles (Feridex; Ad-Vance Magnetics Inc, Rochester, IN, USA) significantly improved the uptake of the nanoparticles by 
the mesenchymal stem cells. The nuclei of the stem cells are labeled in blue, with white arrows identifying some of the magnetically labeled cells; the superparamagnetic iron 
oxide nanoparticles were detected using anti-dextran antibodies. The image shows the mesenchymal stem cells with protamine only (A), with magnetic nanoparticles in the 
absence of protamine (B), and with magnetic nanoparticles of a protamine at concentrations of 1 µg/mL (C) and 5 µg/mL (D). Scale bar is 50 µm. Springer and Methods Mol 
Biol, 906, 2012, 239–252, Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging, 
Jasmin, Torres AL, Jelicks L, de Carvalho AC, Spray DC, Mendez-Otero R, Figure 2.29 with kind permission from Springer Science and Business Media.
Figure 5 Magnetic resonance imaging scan of the damaged temporal lobe of a 
human that received neural stem cells labeled with magnetic nanoparticles.
Notes: The magnetic resonance images show pre- (A) and post-implantation 
(B) of neural stem cells into the temporal lobe. The stem cells are labeled with 
the magnetic nanoparticle, Feridex (Ad-vance Magnetics Inc, Rochester, IN, USA), 
coupled to a transfection reagent. No signal was detected at the lesion, labeled 
with an asterisk, before the injection; however, 1 day post-injection, a dark area 
was seen around the lesion, indicating the presence of the magnetic-labeled neural 
stem cells. Copyright © 2011. John wiley and Sons, Inc. Reproduced from Cromer 
Berman SM, walczak P, Bulte Jw. Tracking stem cells using magnetic nanoparticles. 
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(4):343–355.33
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toxicity, which includes the synthesis of iron-catalyzed reac-
tive oxygen species.44 The cytotoxicity of SPIONs has been 
explored in human mesenchymal stem cells,42 mouse embry-
onic stem cells,23 and neural stem cells45,46 by a variety of 
researchers. It was discovered that on the whole, the internal-
ization of the nanoparticle into these stem cells did not affect 
cell growth or differentiation or, indeed, its viability to survive. 
However, there has been evidence to suggest that endocytic 
lifecycles can be affected due to nanoparticles residing in 
endosomes.45 Studies were undertaken, which showed that it 
is the iron itself within the SPION that caused impairment in 
chondrogenic differentiation, as opposed to any transfection 
factors that were present;46–48 however, other research shows 
that it is the transfection agent, PLL, that causes this effect 
on differentiation (for more toxicity information, see Table 
2). The application of SPIONs in medicine brings a new 
dimension into monitoring stem cells in vitro and in vivo. It 
will allow for groundbreaking research or therapeutic achieve-
ments. However, it is important that with the huge potential 
of this ability to manipulate size, shape, charge, or surface 
modification, detailed studies of toxicity are carried out and 
cell damage with SPIONs checked before clinical application. 
For example, configuration of SPIONs into different shapes 
such as spheres, nanoworms, rod shapes, or beads for different 
functional applications may increase toxicity. This was demon-
strated with mouse L929 fibroblast cells; there was significant 
increased toxicity, despite being at the same molarity as other 
configurations, when the cells were exposed to nanobeads, 
nanoworms, or nanospheres.49 This helps to highlight differ-
ent physicochemical properties such as final size, shape, and 
charge, which will affect the viability of SPIONs. As such, it 
is imperative that further detailed toxicity testing is undertaken 
to assess SPION toxicity and to be aware that new surface 
modification may alter the toxicity of the nanoparticles.
Conclusion
Stem cell therapy has boundless scope and prospects for 
therapeutic and clinical use. In this review, we have focused 
on stem cell tracking using SPIONs. We have discussed and 
evaluated the way in which SPIONS are synthesized, coated, 
and targeted for the use in stem cell tracking. Further to 
this, we have evaluated and discussed the current research 
published pertaining to stem cell tracking in both animal and 
human studies. Researchers across the globe are continuously 
working on ways to improve the techniques already in place, 
and to invent ways to combat limitations. It is, however, a new 
technology that requires further research and understanding. 
Many different types of peptides and different chemical 
 coatings can be conjugated with SPIONs, and greater insights 
and understandings of the complex mechanisms that govern 
human functions are required to maximize the potential of 
the coatings. It is also still not fully clear which cytotoxic and 
hazardous effects the nanoparticles induce; consequentially, it 
will take time to allow them to be used in a clinical scenario. 
A greater understanding of the methods and strategies used 
to produce SPIONs with greater specificity and sensitivity 
are also needed. In summary, much work is still required 
in order to bring SPIONs into a clinical environment. Our 
understanding of many of the physiological mechanisms in 
the body has improved, our knowledge concerning the biol-
ogy of stem cells has increased, and if research continues 
effectively, there is no doubt that nanoparticles, including 
SPIONS, will revolutionize clinical medicine.
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